Skip to main content

Dimethyl fumarate 120 mg
Dimethyl fumarate 240 mg

 

Image
Product Description
  • Sanfedra contains dimethyl fumarate that indicated for the treatment of patients with relapsing forms of multiple sclerosis.
  • FDA-approved as first-line treatment for relapsing forms of multiple sclerosis.
  • Prevents disability worsening and improves quality of life.
  • Reduces risk of multiple sclerosis relapse.
  • Has immunomodulatory and neuroprotective effect.
  • Well-tolerated.